CMNZX | FJMNX | CMNZX / FJMNX | |
Total Expense Ratio | 0.56 | 0.79 | 71% |
Annual Report Gross Expense Ratio | 0.56 | 0.79 | 71% |
Fund Existence | 15 years | 37 years | - |
Gain YTD | -1.400 | -1.045 | 134% |
Front Load | N/A | 4% | - |
Min. Initial Investment | 2000 | 2500 | 80% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 465M | 650M | 72% |
Annual Yield % from dividends | 3.55 | 3.62 | 98% |
Returns for 1 year | -2.10 | -1.25 | 168% |
Returns for 3 years | 2.95 | 4.01 | 73% |
Returns for 5 years | -3.26 | -1.09 | 300% |
Returns for 10 years | 13.99 | 18.23 | 77% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RGAFX | 83.98 | 0.74 | +0.89% |
American Funds Growth Fund of Amer R5 | |||
ECEOX | 12.07 | 0.01 | +0.08% |
Lazard Emerging Markets Core Equity Open | |||
JAGLX | 65.81 | N/A | N/A |
Janus Henderson Global Life Sciences T | |||
JACLX | 18.55 | N/A | N/A |
JHancock Mid Cap Growth C | |||
SMPSX | 35.86 | N/A | N/A |
ProFunds Semiconductor UltraSector Svc |